Johnson Johnson Announces a Lead Vaccine Candidate for COVID...
NEW BRUNSWICK, New Jersey, March 30, 2020 /PRNewswire-AsiaNet/ -- - Johnson & Johnson and BARDA Together Commit More than $1 Billion to Novel Coronavirus Vaccine Research and Development; Company Expects to Initiate Phase 1 Human Clinical Studies of Vaccine Candidate at Latest by September 2020 - Johnson & J...
Authors: LATEST ASIANET NEWS RELEASES